About US

Our History

Founded in 2023, DAMOCLES Diagnostics was born of the collaboration of six experts with complementary skills, ranging from clinical bacteriology to mechatronics, analytical chemistry and in vitro diagnostics. With a shared ambition to revolutionize medical diagnostics, the team joined forces to create an innovative company in the early diagnosis of bacterial infections. DAMOCLES Diagnostics represents team spirit and diversity of talent.

Since its creation, we have filed patents in Europe, the United States and Canada, and published scientific articles in leading international journals.

handsha

2020

Intellectual Property

Technological patent registration

University incubation

AVRUL Incubator

2022

handsha
gps

2023

Startup creation

DAMOCLES Diagnostics

Pre-seed fundraising

800 K€

2024

handsha

OUR TEAM

Nicolas ROUSSELET

CEO

Pr Olivier Barraud

CSO

Dr Audrey Gauthier

CCO & Regulatory Manager

Dr Gaëlle BEGAUD

CSO

Guillaume Bois-Salvaro

CBO

Pr serge battu

Dir. Scientific Advisory Board

Our partners

Our awards

Our publications

2024

GAUTHIER et al., 2024. Sedimentation Field Flow Fractionation for rapid phenotypic antimicrobial susceptibility testing: a pilot study. Journal of Antimicrobial Chemotherapy.

2023

GAUTHIER et al., 2023. Sedimentation Field-Flow Fractionation: A Diagnostic Tool for Rapid Antimicrobial Susceptibility Testing. Analytical Chemistry.